Form:Supplied as a liquid in PBS with 0.02% sodium azide.
Specificity:Recognizes the human Her2/neu (also known as c-erbB-2) proto-oncogene, which is expressed at the cell surface of a range of tumor cells. In many types of tumor Her2/neu expression is related to poor prognosis, with an increased risk of metastasis. ICR55 recognizes epitope E of Her2/neu.